Royalty Pharma Plc (RPRX) institutional holders · P/E 34, rev $2.38B
No cached 13F filings for quarters ended 2026-06-30 or later list Royalty Pharma Plc yet.
No current-quarter cached 13F holders for RPRX yet.
These 13F holders as JSON? API free 100/dayRPRX institutional holders FAQ
What is RPRX's P/E ratio?
Royalty Pharma Plc (RPRX) trailing P/E is 34.1 on the latest cached fundamentals snapshot.
What is RPRX's latest revenue?
Latest cached Royalty Pharma Plc (RPRX) revenue for Dec 31, 2025 was $2.38B. Statements: https://lician.com/financials/rprx
Not investment advice. Cached rows, not a live tape.